AU2023233426A1 - Zinc finger degron sequences - Google Patents

Zinc finger degron sequences Download PDF

Info

Publication number
AU2023233426A1
AU2023233426A1 AU2023233426A AU2023233426A AU2023233426A1 AU 2023233426 A1 AU2023233426 A1 AU 2023233426A1 AU 2023233426 A AU2023233426 A AU 2023233426A AU 2023233426 A AU2023233426 A AU 2023233426A AU 2023233426 A1 AU2023233426 A1 AU 2023233426A1
Authority
AU
Australia
Prior art keywords
zinc finger
finger domain
hybrid
amino acid
cys
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
AU2023233426A
Other languages
English (en)
Inventor
Ali Can SAHILLIOGLU
Antonius Nicolaas Maria Schumacher
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Netherlands Cancer Institute
Original Assignee
Netherlands Cancer Institute
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Netherlands Cancer Institute filed Critical Netherlands Cancer Institute
Publication of AU2023233426A1 publication Critical patent/AU2023233426A1/en
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4702—Regulators; Modulating activity
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4702—Regulators; Modulating activity
    • C07K14/4703—Inhibitors; Suppressors
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10—Transferases (2.)
    • C12N9/1025—Acyltransferases (2.3)
    • C12N9/104—Aminoacyltransferases (2.3.2)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/80—Fusion polypeptide containing a DNA binding domain, e.g. Lacl or Tet-repressor
    • C07K2319/81—Fusion polypeptide containing a DNA binding domain, e.g. Lacl or Tet-repressor containing a Zn-finger domain for DNA binding
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/95—Fusion polypeptide containing a motif/fusion for degradation (ubiquitin fusions, PEST sequence)

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biophysics (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
AU2023233426A 2022-03-18 2023-03-17 Zinc finger degron sequences Pending AU2023233426A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
NL2031325 2022-03-18
NL2031325A NL2031325B1 (en) 2022-03-18 2022-03-18 Novel zinc finger degron sequences
PCT/NL2023/050136 WO2023177296A1 (en) 2022-03-18 2023-03-17 Zinc finger degron sequences

Publications (1)

Publication Number Publication Date
AU2023233426A1 true AU2023233426A1 (en) 2024-10-31

Family

ID=82483007

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2023233426A Pending AU2023233426A1 (en) 2022-03-18 2023-03-17 Zinc finger degron sequences

Country Status (9)

Country Link
US (1) US20250206789A1 (https=)
EP (1) EP4493696A1 (https=)
JP (1) JP2025509853A (https=)
CN (1) CN118922547A (https=)
AU (1) AU2023233426A1 (https=)
CA (1) CA3255620A1 (https=)
IL (1) IL315649A (https=)
NL (1) NL2031325B1 (https=)
WO (1) WO2023177296A1 (https=)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL2033636B1 (en) 2022-11-29 2024-06-04 Stichting Het Nederlands Kanker Inst Antoni Van Leeuwenhoek Ziekenhuis Receptor- and drug-dependent regulated on-site production of biologicals.
NL2037809B1 (en) 2024-05-29 2025-12-12 Cell Control Biotherapeutics Inc Loop reinforcement expression system for improved cell therapy products

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB201710620D0 (en) 2017-07-03 2017-08-16 Glaxosmithkline Intellectual Property Ltd Targeted protein degradation
US12049482B2 (en) 2017-10-31 2024-07-30 The Brigham And Women's Hospital, Inc. Molecular switch-mediated control of engineered cells
WO2020132039A2 (en) 2018-12-18 2020-06-25 Dana-Farber Cancer Institute, Inc. Peptide tags for ligand induced degradation of fusion proteins
CN111907552B (zh) 2019-07-17 2021-08-13 中车大同电力机车有限公司 机车牵引装置及其调整方法
EP4048301B1 (en) 2019-10-23 2024-09-18 Stichting Het Nederlands Kanker Instituut- Antoni van Leeuwenhoek Ziekenhuis Chimeric polypeptide for regulating immune cells
US20230151342A1 (en) 2020-02-28 2023-05-18 The Broad Institute, Inc Zinc finger degradation domains

Also Published As

Publication number Publication date
EP4493696A1 (en) 2025-01-22
NL2031325B1 (en) 2023-09-29
US20250206789A1 (en) 2025-06-26
CN118922547A (zh) 2024-11-08
WO2023177296A1 (en) 2023-09-21
JP2025509853A (ja) 2025-04-11
CA3255620A1 (en) 2023-09-21
IL315649A (en) 2024-11-01

Similar Documents

Publication Publication Date Title
TWI908706B (zh) ＣＡＲＴｙｒｉｎ組成物和使用方法
TWI905076B (zh) 非複製勝任型重組反轉錄病毒顆粒及其用途
AU2014364949B2 (en) Single chain IL-12 nucleic acids, polypeptides, and uses thereof
CN111727256A (zh) 用于嵌合配体受体（clr）-介导的条件性基因表达的组合物和方法
WO2017142855A1 (en) Immunomodulatory agents and methods of use thereof
EP4493696A1 (en) Zinc finger degron sequences
US20230192794A1 (en) Engineered interleukin-22 polypeptides and uses thereof
JP7097465B2 (ja) キメラ抗原受容体細胞療法と併用するｉｌ－１０剤の組成およびその使用方法
US20220040329A1 (en) Inducible expression cassette, and uses thereof
IL298471A (en) Engineered interleukin-10 polypeptides and uses thereof
KR20210132109A (ko) Dna-결합 도메인 전사활성화제 및 이의 용도
Henzi et al. Soluble dimeric prion protein ligand activates Adgrg6 receptor but does not rescue early signs of demyelination in PrP-deficient mice
JP7848138B2 (ja) 改変型上皮成長因子受容体及び細胞追跡におけるその使用
KR20230056706A (ko) 재조합 형질전환 성장 인자(tgf)-베타 단량체를 암호화하는 종양용해 바이러스 및 이의 용도
TW202334398A (zh) 組成型細胞激素受體
AU2023400571A1 (en) Receptor- and drug-dependent regulated on-site production of biologicals
HK40086533A (zh) 编码重组转化生长因子(TGF)-β单体的溶瘤病毒及其用途
JP4750364B2 (ja) アポトーシスを伴う疾患の予防又は治療剤